HK1247826A1 - 吡咯甲酰胺的固體組合物 - Google Patents
吡咯甲酰胺的固體組合物Info
- Publication number
- HK1247826A1 HK1247826A1 HK18107273.3A HK18107273A HK1247826A1 HK 1247826 A1 HK1247826 A1 HK 1247826A1 HK 18107273 A HK18107273 A HK 18107273A HK 1247826 A1 HK1247826 A1 HK 1247826A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- solid composition
- pyrrole carboxamide
- carboxamide
- pyrrole
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015012252 | 2015-01-26 | ||
| PCT/JP2016/051956 WO2016121664A1 (ja) | 2015-01-26 | 2016-01-25 | ピロールカルボキサミドの固形組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1247826A1 true HK1247826A1 (zh) | 2018-10-05 |
Family
ID=56543277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18107273.3A HK1247826A1 (zh) | 2015-01-26 | 2018-06-04 | 吡咯甲酰胺的固體組合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10034855B2 (zh) |
| EP (1) | EP3251669B1 (zh) |
| JP (1) | JP6707471B2 (zh) |
| KR (1) | KR102488167B1 (zh) |
| CN (1) | CN107205984B (zh) |
| BR (1) | BR112017015788B1 (zh) |
| CA (1) | CA2973944C (zh) |
| ES (1) | ES2832465T3 (zh) |
| HK (1) | HK1247826A1 (zh) |
| TW (1) | TWI686195B (zh) |
| WO (1) | WO2016121664A1 (zh) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3506276C1 (de) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
| FR2752162B1 (fr) * | 1996-08-07 | 1998-11-06 | Jouveinal Lab | Comprime de maleate de trimebutine pellicule |
| MXPA06014587A (es) * | 2004-06-17 | 2007-04-27 | Forest Laboratories | Formulaciones de liberacion modificada de formulaciones de dosificacion oral de memantina. |
| PT1773768T (pt) * | 2004-07-30 | 2018-11-30 | Exelixis Inc | Derivados de pirrol como agentes farmacêuticos |
| PT2133330E (pt) | 2007-04-09 | 2014-03-31 | Daiichi Sankyo Co Ltd | Atropisómero de derivado de pirrole |
| JP2010111657A (ja) * | 2008-10-07 | 2010-05-20 | Daiichi Sankyo Co Ltd | ピロール誘導体のアトロプ異性体を含有する医薬 |
| EP2359813A1 (en) * | 2010-02-04 | 2011-08-24 | Ratiopharm GmbH | Pharmaceutical composition comprising N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid |
| KR101725462B1 (ko) * | 2012-10-12 | 2017-04-11 | 이에이 파마 가부시키가이샤 | 칼슘 길항약／안지오텐신 ｉｉ 수용체 길항약 함유 의약 제제 |
| JP6027911B2 (ja) * | 2013-02-18 | 2016-11-16 | フロイント産業株式会社 | 賦形剤造粒物及びその製造方法、並びに錠剤 |
| JP6107226B2 (ja) * | 2013-02-26 | 2017-04-05 | ニプロ株式会社 | 医薬組成物 |
| JP5689192B2 (ja) * | 2014-02-21 | 2015-03-25 | 大日本住友製薬株式会社 | 光安定性の向上した組成物 |
-
2016
- 2016-01-25 CN CN201680007114.6A patent/CN107205984B/zh active Active
- 2016-01-25 BR BR112017015788-8A patent/BR112017015788B1/pt active IP Right Grant
- 2016-01-25 KR KR1020177019890A patent/KR102488167B1/ko active IP Right Grant
- 2016-01-25 ES ES16743267T patent/ES2832465T3/es active Active
- 2016-01-25 WO PCT/JP2016/051956 patent/WO2016121664A1/ja active Application Filing
- 2016-01-25 CA CA2973944A patent/CA2973944C/en active Active
- 2016-01-25 JP JP2016571999A patent/JP6707471B2/ja active Active
- 2016-01-25 EP EP16743267.3A patent/EP3251669B1/en active Active
- 2016-01-26 TW TW105102294A patent/TWI686195B/zh active
-
2017
- 2017-07-26 US US15/660,625 patent/US10034855B2/en active Active
-
2018
- 2018-06-04 HK HK18107273.3A patent/HK1247826A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016121664A1 (ja) | 2016-08-04 |
| CA2973944A1 (en) | 2016-08-04 |
| CN107205984B (zh) | 2019-11-12 |
| KR20170104486A (ko) | 2017-09-15 |
| EP3251669A4 (en) | 2018-07-25 |
| EP3251669B1 (en) | 2020-09-02 |
| JPWO2016121664A1 (ja) | 2017-11-02 |
| BR112017015788A2 (pt) | 2018-03-27 |
| US10034855B2 (en) | 2018-07-31 |
| TWI686195B (zh) | 2020-03-01 |
| KR102488167B1 (ko) | 2023-01-12 |
| TW201630601A (zh) | 2016-09-01 |
| BR112017015788B1 (pt) | 2023-05-16 |
| EP3251669A1 (en) | 2017-12-06 |
| JP6707471B2 (ja) | 2020-06-10 |
| CA2973944C (en) | 2019-07-30 |
| US20170319544A1 (en) | 2017-11-09 |
| ES2832465T3 (es) | 2021-06-10 |
| CN107205984A (zh) | 2017-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL257026A (en) | Solid state forms of eluxadoline | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| PL3059223T3 (pl) | Wytwarzanie mieszanin estrów | |
| SI3102555T1 (sl) | Sestavki spojin in njihove uporabe | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| GB201521353D0 (en) | Methods of surface-mounting components | |
| IL287520A (en) | Levetiracetam extended-release pharmaceutical preparations | |
| IL259796A (en) | Aza-benzimidazole inhibitors of pad4 | |
| PL3349743T3 (pl) | Sposoby i kompozycje do hamowania oddziaływania dcn1-ubc12 | |
| IL274627A (en) | Solid state form of valbenazine | |
| IL265628A (en) | Solid state forms of valbenazine | |
| SI3845221T1 (sl) | Trdne oblike sofosbuvirja | |
| HU4602U (en) | Set of saggar assembly | |
| ZA201706282B (en) | Solid forms of menaquinols | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| IL263673A (en) | Solid state forms of spiro-oxindole compounds | |
| HU4603U (en) | Set of saggar assembly | |
| IL255182A0 (en) | History of korormicim with antibiotic use | |
| PL3344070T3 (pl) | Jadalna kompozycja | |
| HK1248569A1 (zh) | 用於防止白髮的組合物 | |
| IL254666A0 (en) | Crystalline forms of Aldecalcitol | |
| HK1247826A1 (zh) | 吡咯甲酰胺的固體組合物 | |
| IL247645A0 (en) | Preparations of seleno-organic compounds and methods of using them | |
| GB201510870D0 (en) | Treatment of infarction | |
| GB201721386D0 (en) | Chrondogy of time-wave |